How many UTIs constitute a recurrent UTI?

A recurrent UTI is medically defined as two or more confirmed urinary tract infections within a 6-month period, or three or more infections within a 12-month period.

Why do I keep getting UTIs even after taking antibiotics?

Recurrent UTIs despite antibiotic treatment can occur due to antibiotic resistance, reinfection, incomplete eradication, or underlying anatomical or hormonal factors. A specialist evaluation with urine culture is essential.

Can recurrent UTIs be prevented?

Yes - recurrent UTIs can often be significantly reduced or eliminated with the right prevention strategy including low-dose antibiotic prophylaxis, vaginal estrogen therapy for postmenopausal women, behavioral modifications, and evidence-based supplements.

Do I need to see an infectious disease specialist or can my primary care doctor treat recurrent UTIs?

While primary care physicians can treat individual UTI episodes, recurrent UTIs benefit significantly from infectious disease specialist evaluation with specialized training in antibiotic resistance patterns and evidence-based prevention strategies.

Is long-term antibiotic use for UTI prevention safe?

Low-dose antibiotic prophylaxis for recurrent UTI prevention has a well-established safety record when properly managed. Specialists carefully select the safest antibiotic at the lowest effective dose and regularly reassess.

Does Atlas IDP accept insurance for recurrent UTI treatment?

Yes, Atlas Infectious Disease Practice accepts most major insurance plans. Call (561) 995-6971 to verify your specific insurance coverage before your appointment.

General Infectious Disease Archives

Login / Signup

Top Infectious Disease News Stories Week of January 10 – January 16

A Therapeutic Challenge: Quadruple-Valve Endocarditis Resulting From Injection Drug Use

“Moderate” Evidence Supports Latest Pentavalent Meningococcal Vaccine as Alternative to Separate Quadrivalent and MenB

Vitamin A may be helping cancer hide from the immune system

Infectious Disease Regulatory Watch: December Highlights

Protectors vs Police: How Antimicrobial Stewardship Interventions Come Across and How to Change the Narrative

Pertussis Cases Surge in Young Children, Adolescents Due to Reduced Vaccine Uptake

A No-Carb Diet: An Overview of Non–Carbapenemase-Producing Carbapenem-Resistant Enterobacterales

Phase 3 Clinical Trial Reporting, Prospective Regulatory Filings to Watch For in 2026

Invasive Fungal Disease in Transplantation: Prevention in a Shifting Landscape

Schedule an Appointment

Quick Links

Patient Forms

Contact Us